.
Key documents
- Statement on air freight of critical medicines & supplies
- Best practice guidance on how to protect workers in relation to Covid-19
- Critical to keep the supply chain of essential medicines manufacturing operating at full capacity
- EMA clarifies no scientific evidence to deter use of ibuprofen to manage coronavirus symptoms
- Impact of COVID-19 on active ingredient and medicines manufacturing and supplies in Europe
- Coordination with industry on potential impact of Covid-19 on medicines manufacturing and supplies in Europe
- Medicines for Europe statement on COVID-19 (‘coronavirus’)
- Medicines for Europe urgent requests to Interior & Transport ministries regarding medicines production and supply
- Medicines for Europe update regarding medicines production and supply related to Covid-19
Useful links
- MOH JO: Coronavirus (COVID-19)
- EMA: Coronavirus disease (COVID-19)
- WHO: Coronavirus disease (COVID-19) outbreak
- CDC: Coronavirus (COVID-19)
- Worldmeters: COVID-19 CORONAVIRUS PANDEMIC